Results 151 to 160 of about 18,115 (178)

Protocol for Measuring Drug-Target Engagement in Mouse Colorectal Cancer Organoids Using NanoBRET Assay. [PDF]

Bio Protoc
Badmos HA, Steele C, Cagan R.
europepmc   +1 more source

CEA and CA-19-9 Dynamics Associate with Survival in Regorafenib-Treated Metastatic Colorectal Cancer: A Real-World Analysis. [PDF]

J Clin Med
Yalçıner M, Örüncü MB, Kayaalp M, Erdat EC, Kavak EE, Utkan G.   +5 more
europepmc   +1 more source

A novel kinase inhibitor, Regorafenib, blocks EGFR-dependent signaling to repress tumour metastasis in human triple-negative breast cancers. [PDF]

Front Cell Dev Biol
Zhao L, Wang C, Wang Y, Liu M, Du H, Chu X, Yang W, Zhao W, Wang G, Zhang B, Zhang Y, Meng Y, Li H, Wen P, Liu Y.   +14 more
europepmc   +1 more source

Trifluridine/Tipiracil Plus Bevacizumab Versus Regorafenib in Elderly Patients with Refractory Metastatic Colorectal Cancer: A Real-World Comparative Study. [PDF]

Cancers (Basel)
Tseng YK, Lin CL, Chiang SW, Chiang FF.
europepmc   +1 more source

Phenotypic Response Surfaces-Guided Optimization (PRS-OPT) of Propolis-Metformin-Regorafenib Combination Therapy for MASLD-Associated Hepatocellular Carcinoma. [PDF]

Oncol Res
Huang YS, Ma CY, Roan HY, Chiang CH, Tsou HH, Chen CH, Lin YF, Wang HD, Yuh CH.   +8 more
europepmc   +1 more source

Single-cell RNA sequencing reveals immune-peritubular myoid cell crosstalk driving testicular interstitial fibrosis in idiopathic non-obstructive azoospermia. [PDF]

Cell Biosci
Tan X, Zhang J, Yang Q, Zhu K, Hou Y, Guo Z, Li X, Deng H, Chen C, Deng C, Sun X, Chen Y, Chen Z.   +12 more
europepmc   +1 more source

Effectiveness of primary tumor resection for survival after first-line cetuximab or bevacizumab in KRAS wild-type metastatic colorectal cancer treated with subsequent trifluridine/tipiracil or regorafenib. [PDF]

Ann Coloproctol
Chen YH, Wu CC, Su CC, Lee PT, Su YC.
europepmc   +1 more source

Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study. [PDF]

ESMO Open
Moik F, Huemer F, Doleschal B, Taghizadeh H, Reimann P, Kostmann SM, Wagner L, Abdel Hamid M, Zimmer KC, Suppé SA, Bachleitner C, Schaberl-Moser R, Amann A, Wolf D, Greil R, Jost PJ, Winder T, Rumpold H, Weiss L, Gerger A, Seeber A, Riedl JM.   +21 more
europepmc   +1 more source

Regorafenib in refractory gastric cancer: modest median, meaningful milestone. [PDF]

J Gastrointest Oncol
Narita Y, Muro K.
europepmc   +1 more source

Immunotherapy Rechallenge in HCC: A Second Chance for Response? [PDF]

Liver Int
Da Fonseca LG, Guerrero A, Muñoz-Martínez SG.   +2 more
europepmc   +1 more source